Literature DB >> 2804672

Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.

J Kornhuber1, C Konradi, F Mack-Burkhardt, P Riederer, H Heinsen, H Beckmann.   

Abstract

The effect of several antemortem and postmortem factors (patients' age, sex, postmortem delay, storage time, laterality and brain weight) on both monoamine oxidase-A (MAO-A) and -B (MAO-B) activity was investigated in the frontal cortex of human brains. The MAO-A activity decreases rapidly during the first two years of life and remains constant thereafter. In contrast, the MAO-B activity keeps unchanged during early childhood and raises during advanced age. These findings seem to be consistent with a genetic regulation and a variation in cell type assembling during brain development and aging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804672     DOI: 10.1016/0006-8993(89)91136-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.

Authors:  Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

Review 2.  Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.

Authors:  Linda Booij; Richard E Tremblay; Moshe Szyf; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

Review 3.  Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets.

Authors:  Orit Bar-Am; Tamar Amit; Moussa B Youdim; Orly Weinreb
Journal:  J Neural Transm (Vienna)       Date:  2015-04-10       Impact factor: 3.575

Review 4.  Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Authors:  Éva Szökő; Tamás Tábi; Peter Riederer; László Vécsei; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

5.  Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.

Authors:  Beata Karolewicz; Violetta Klimek; He Zhu; Katalin Szebeni; Emily Nail; Craig A Stockmeier; Laurel Johnson; Gregory A Ordway
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

Review 6.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

Review 7.  Neurotransmission and the ontogeny of human brain.

Authors:  W Retz; J Kornhuber; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Authors:  Junchao Tong; Jeffrey H Meyer; Yoshiaki Furukawa; Isabelle Boileau; Li-Jan Chang; Alan A Wilson; Sylvain Houle; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

9.  Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.

Authors:  Paraskevi Vivien Rekkas; Alan A Wilson; Vivian Wai Han Lee; Priyanga Yogalingam; Julia Sacher; Pablo Rusjan; Sylvain Houle; Donna E Stewart; Nathan J Kolla; Stephen Kish; Lina Chiuccariello; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2014-08       Impact factor: 21.596

10.  Monoamine oxidase-B-positive granular structures in the hippocampus of aged senescence-accelerated mouse (SAMP8).

Authors:  S Nakamura; I Akiguchi; N Seriu; K Ohnishi; M Takemura; M Ueno; H Tomimoto; T Kawamata; J Kimura; M Hosokawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.